Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Fresenius Kabi Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (285)
Cancellation by sponsor (141)
Prescription medicine registration (13)
Australian public assessment report (AusPar) (6)
Prescription medicine decision summary (2)

Date

2026 (10)
2025 (21)
2024 (49)
2023 (45)
2022 (28)
2021 (13)
2020 (29)
2019 (56)
2018 (15)
2017 (14)
2016 (18)
2015 (19)
2014 (7)
2013 (25)
2012 (18)
2011 (5)
2010 (5)
2009 (1)
2008 (13)
2007 (12)
2006 (26)
2002 (2)
2001 (2)
1994 (5)
1992 (3)
1991 (6)

Search

Sponsor content

447 result(s) found, displaying 101 to 110

PICOPREP Powder for solution Cancelled under Section 30(1)(c) of the Act

1 December 2023

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
GLYCOPREP-C Flavoured Gastrointestinal lavage powder for solution Cancelled under Section 30(1)(c) of the Act

1 December 2023

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
PREPKIT C Cancelled under Section 30(1)(c) of the Act

1 December 2023

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
GLYCOPREP-C KIT Cancelled under Section 30(1)(c) of the Act

1 December 2023

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
CEFTRIAXONE KABI ceftriaxone (as sodium) 2 g powder for injection vial Cancelled under Section 30(1)(c) of the Act

30 November 2023

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
CEFTRIAXONE KABI ceftriaxone (as sodium) 1 g powder for injection vial Cancelled under Section 30(1)(c) of the Act

30 November 2023

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
CEFTRIAXONE KABI ceftriaxone (as sodium) 0.5 g powder for injection vial Cancelled under Section 30(1)(c) of the Act

30 November 2023

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
Fresenius Kabi Australia Pty Ltd - Apheresis unit (393046)

28 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Ltd - Apheresis unit.
Fresenius Kabi Australia Pty Ltd - Apheresis system tubing set (393048)

28 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Ltd - Apheresis system tubing set.
Fresenius Kabi Australia Pty Ltd - Electrical-only medical device connection adaptor (392332)

15 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Fresenius Kabi Australia Pty Ltd - Electrical-only medical device connection adaptor.

Pages

First page
Previous page
…
Page 7
Page 8
Page 9
Page 10
Current page 11
Page 12
Page 13
Page 14
Page 15
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.